SCHEMBL18914698

SCHEMBL18914698

O=S(=O)(CCCCl)N1CCC(O)C1

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.38
JAK2 O60674 2/20 0.33
JAK1 P23458 2/20 0.33
JAK3 P52333 2/20 0.33
KCNH2 Q12809 1/20 0.31
HRH3 Q9Y5N1 1/20 0.31
KMT2A Q03164 1/20 0.31
CYP1A2 P05177 1/20 0.31
LMNA P02545 3/20 0.31
ALDH1A1 P00352 2/20 0.31
CNR2 P34972 1/20 0.30
BRD4 O60885 1/20 0.30
NPC1 O15118 1/20 0.30
KDM4E B2RXH2 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21795445 0.77 KDM4E (0.42) JAK2JAK1JAK3KCNH2HRH3
SCHEMBL13411082 0.75 TSHR (0.45) EPHX2KMT2ALMNAALDH1A1NPC1
SCHEMBL24571244 0.75 EPHX2 (0.40) EPHX2JAK2JAK1JAK3LMNA
SCHEMBL13411081 0.73 LMNA (0.51) EPHX2LMNAALDH1A1NPC1KDM4E
SCHEMBL13411083 0.73 EPHX2 (0.49) EPHX2CYP1A2LMNAALDH1A1NPC1
SCHEMBL16235813 0.71 EPHX2 (0.38) EPHX2KMT2AALDH1A1KDM4E
SCHEMBL1770819 0.71 EPHX2 (0.38) EPHX2KMT2AALDH1A1KDM4E
SCHEMBL13411080 0.71 EPHX2 (0.38) EPHX2JAK2JAK1JAK3LMNA
SCHEMBL3576015 0.71 TP53 (0.35) KCNH2HRH3LMNAALDH1A1CNR2
SCHEMBL3576010 0.71 TP53 (0.35) KCNH2HRH3LMNAALDH1A1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3381913-B1 2-(((PYRROLIDIN-3-YL)CARBONYL)AMINO)-1H-IMIDAZOLE DERIVATIVES AS MELANOCORTIN RECEPTOR 1 (MCR1) AGONISTS FOR TREATING RHEUMATOID ARTHRITIS MITSUBISHI TANABE PHARMA CORP (JP) 2021-03-31 EP disclosed
WO-2017090743-A1 NOVEL IMIDAZOLE COMPOUND AND USE THEREOF AS MELANOCORTIN RECEPTOR AGONIST 田辺三菱製薬株式会社 2017-06-01 WO disclosed